Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
hERG1 potassium channel in cancer cells: a tool to reprogram immortality
1Loyola University Chicago, Maywood, IL, USA. sagentile@luc.edu.
Abstract:
It has been well established that changes in ion fluxes across cellular membranes as a function of time is fundamental in maintaining cellular homeostasis of every living cell. Consequently, dysregulation of ion channels activity is a critical event in pathological conditions of several tissues, including cancer. Nevertheless, the role of ion channels in cancer biology is still not well understood and very little is known about the possible therapeutic opportunities offered by the use of the vast collection of drugs that target ion channels. In this review, we focus on the recent advances in understanding the role of the voltage-gated hERG1 potassium channel in cancer and on the effects of pharmacologic manipulation of the hERG1 in cancer cells aiming to provide insights into the biochemical signaling and cellular processes that are altered by using these drugs.
Insights
Dysregulation of ion channels, like the hERG1 potassium channel, is critical in cancer. This review explores hERG1
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Ion fluxes across cellular membranes are crucial for cellular homeostasis.
- Ion channel dysregulation is implicated in various pathological conditions, including cancer.
- The specific role of ion channels in cancer biology and their therapeutic potential remain underexplored.
Purpose of the Study:
- To review recent advances in understanding the voltage-gated hERG1 potassium channel's role in cancer.
- To examine the effects of pharmacologic manipulation of hERG1 in cancer cells.
- To provide insights into altered biochemical signaling and cellular processes due to hERG1 drug targeting.
Main Methods:
- Literature review focusing on voltage-gated hERG1 potassium channel in cancer.
- Analysis of studies investigating pharmacologic manipulation of hERG1 in cancer cells.
- Synthesis of current knowledge on hERG1's impact on cancer cell signaling and processes.
Main Results:
- The voltage-gated hERG1 potassium channel plays a significant role in cancer biology.
- Pharmacologic targeting of hERG1 affects key biochemical signaling and cellular processes in cancer cells.
- Emerging evidence suggests therapeutic opportunities for hERG1-targeting drugs in cancer treatment.
Conclusions:
- The hERG1 potassium channel is a relevant target for cancer therapy.
- Further research into hERG1's function and drug interactions is warranted to optimize cancer treatment strategies.
- Understanding hERG1's role can lead to novel therapeutic approaches for various cancers.
Related Concept Videos
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Non-gated Ion Channels
G-Protein Gated Ion Channels
Sensory...
Mitogens and the Cell Cycle
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

